Related Experiment Video
Updated: Sep 12, 2025

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
Published on: August 9, 2024
IMforte: A new starting point and new challenges
1Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China.
The IMforte study1 demonstrated that maintenance treatment with atezolizumab plus lurbinectedin significantly improved progression-free survival and overall survival in patients with extensive-stage small cell lung cancer (ES-SCLC). This phase 3 study is the first to report a positive result in first-line maintenance therapy for ES-SCLC, representing another milestone that is likely to establish a new standard of care for this condition.
The IMforte study1 demonstrated that maintenance treatment with atezolizumab plus lurbinectedin significantly improved progression-free survival and overall survival in patients with extensive-stage small cell lung cancer (ES-SCLC). This phase 3 study is the first to report a positive result in first-line maintenance therapy for ES-SCLC, representing another milestone that is likely to establish a new standard of care for this condition.
Related Concept Videos
Migration
Motivational Cycle
The cycle begins with a need. This need can arise from various conditions, such as hunger, thirst, or temperature changes. For instance, when an individual feels cold, their body...
Introduction to force
Initiation of Translation
Internal and External Forces
Transformation

